 |
|
|
 |
||
|
|
|
|
Anthrax Vaccines |
It is quite clear that the current anthrax military vaccine does NOT work. There have NEVER been ANY efficacy studies as the following text is taken verbatim from the December 13, 1985, issue of the Federal Register states.
It reports on the findings of an independent civilian advisory panel that considered the evidence for the safety and efficacy of vaccines available in the 1970s. The end of the document reports FDA's actions in response to the panel's recommendations. The entire report is 115 pages long (pages 51002 through 51117). This report is taken from a US military web site.
Efficacy
The best evidence for the efficacy of anthrax vaccine comes from a placebo-controlled field trial conducted by Brachman (Ref. 1) covering four mills processing raw imported goathair into garment underlinings. The study involved approximately 1,200 mill employees of whom about 40 percent received the vaccine and the remainder received the placebo or nothing. The average yearly incidence of clinical anthrax in this population was 1 percent.
During the evaluation period, 26 cases of anthrax occurred. Twenty-one had received no vaccine, four had incomplete immunization and one had complete immunization. Based upon analysis of attack rates per 1000 person-months,
The vaccine was calculated to give 93 percent protection against cutaneous anthrax.
Inhalation anthrax occurred too infrequently to assess the protective effect of the vaccine against this form of the disease.
Department of Health and Human Services Food and Drug Administration, Federal Register Vol. 50, No. 240 December 13, 1985, Part II
DR. FARR'S COMMENT:
OK people, GET THIS: the statement above in big white bold is the KEY.
The US Military vaccine has NEVER been tested against inhalation anthrax. That is the type that will be the most devastating. It has only been tested against cutaneous (skin) anthrax.
In simpler terms, this means the US human approved anthrax vaccine is virtually worthless against biological terrorism. They were able to get away with this nonsense as the vaccine was introduced in 1970 which is two years before efficacy studies were required before a vaccine could be released.
The US vaccine was used only by several thousand people until 1990. There have been no controlled clinical trials in humans of the efficacy of the currently licensed US vaccine.
The article does go on to state indications where the vaccine should not be administered.
1. A history of clinical anthrax infection which may enhance the risk of severe reactions.
2. Severe systemic reactions with marked chills and fever following a prior injection - in this case further attempts at immunization should be abandoned.
3. The presence of acute respiratory disease or other febrile illnesses in order not to confuse the cause of further fever.
4. Therapy with corticosteroids or other immunosuppressive agents - in this case immunization should be deferred until such therapy has been completed. If on a long-term therapy, a more intensive immunization schedule should be considered.
5. Pregnancy is a Category C. DO NOT ADMINISTER.
Reference
Brachman, P.S., H. Gold, S.A. Plotkin, R. Fekety, M. Werrin, and N.R. Ingraham, "Field Evaluation of a Human Anthrax Vaccine," American Journal of Public Health, 52:632-645, 1962
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
